Annual report pursuant to Section 13 and 15(d)

BUSINESS SEGMENT AND GEOGRAPHIC REPORTING

v3.19.2
BUSINESS SEGMENT AND GEOGRAPHIC REPORTING
12 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
NOTE 11 - BUSINESS SEGMENT AND GEOGRAPHIC REPORTING

The Company determined its operating segments in accordance with ASC 280, “Segment Reporting” (“ASC 280”).

 

Management has determined that the Company has one operating segment. The Company’s reporting segment reflects the manner in which its chief operating decision maker reviews results and allocates resources. The Company’s reporting segment meets the definition of an operating segment and does not include the aggregation of multiple operating segments.

 

Customers

 

The Company derives its revenues from services and products within the cannabinoid therapeutics / biopharmaceuticals CBD industry with no one external customer accounting for more than 10% of its revenue. Total revenues from these products and services were $707,062 and $197,554 for the fiscal year ended March 31, 2019 and 2018, respectively.

 

Geographic Information

 

All material revenues of the Company are derived from the United States. All long-lived assets of the Company are located in the United States.